Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $6.10 $80.02 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $71.43 $25.28
52 weeks $0.340 $25.28

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Jul 21, 2016 $24.64 $24.64 $24.64 $24.64 42 888
Jul 20, 2016 $24.56 $24.56 $24.56 $24.56 63 775
Jul 19, 2016 $24.64 $24.64 $24.64 $24.64 54 725
Jul 18, 2016 $26.32 $26.32 $26.32 $26.32 45 275
Jul 15, 2016 $26.32 $26.32 $26.32 $26.32 73 500
Jul 14, 2016 $25.68 $25.68 $25.68 $25.68 108 363
Jul 13, 2016 $27.28 $27.28 $27.28 $27.28 76 013
Jul 12, 2016 $29.44 $29.44 $29.44 $29.44 62 388
Jul 11, 2016 $29.44 $29.44 $29.44 $29.44 97 313
Jul 08, 2016 $30.48 $30.48 $30.48 $30.48 273 388
Jul 07, 2016 $27.04 $27.04 $27.04 $27.04 41 738
Jul 06, 2016 $26.48 $26.48 $26.48 $26.48 83 663
Jul 05, 2016 $25.92 $25.92 $25.92 $25.92 32 975
Jul 01, 2016 $25.44 $25.44 $25.44 $25.44 38 925
Jun 30, 2016 $24.72 $24.72 $24.72 $24.72 53 750
Jun 29, 2016 $24.72 $24.72 $24.72 $24.72 107 338
Jun 28, 2016 $24.56 $24.56 $24.56 $24.56 59 675
Jun 27, 2016 $23.92 $23.92 $23.92 $23.92 76 688
Jun 24, 2016 $25.36 $25.36 $25.36 $25.36 168 600
Jun 23, 2016 $24.80 $24.80 $24.80 $24.80 39 288
Jun 22, 2016 $24.24 $24.24 $24.24 $24.24 64 575
Jun 21, 2016 $24.64 $24.64 $24.64 $24.64 69 575
Jun 20, 2016 $24.80 $24.80 $24.80 $24.80 73 788
Jun 17, 2016 $23.84 $23.84 $23.84 $23.84 80 913
Jun 16, 2016 $25.12 $25.12 $25.12 $25.12 71 378
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT